Additional SNPs improve the performance of a polygenic hazard score for prostate cancer
Roshan A. Karunamuni, View ORCID ProfileMinh-Phuong Huynh-Le, Chun C. Fan, Wesley Thompson, Rosalind A. Eeles, Zsofia Kote-Jarai, Kenneth Muir, Artitaya Lophatananon, UKGPCS collaborators, Johanna Schleutker, Nora Pashayan, Jyotsna Batra, APCB BioResource (Australian Prostate Cancer BioResource), Henrik Grönberg, Eleanor I. Walsh, Emma L. Turner, Athene Lane, Richard M. Martin, David E. Neal, Jenny L. Donovan, Freddie C. Hamdy, Børge G. Nordestgaard, Catherine M. Tangen, Robert J. MacInnis, Alicja Wolk, Demetrius Albanes, Christopher A. Haiman, Ruth C. Travis, Janet L. Stanford, Lorelei A. Mucci, Catharine M. L. West, Sune F. Nielsen, Adam S. Kibel, Fredrik Wiklund, Olivier Cussenot, Sonja I. Berndt, Stella Koutros, Karina Dalsgaard Sørensen, Cezary Cybulski, Eli Marie Grindedal, Jong Y. Park, Sue A. Ingles, Christiane Maier, Robert J. Hamilton, Barry S. Rosenstein, Ana Vega, The IMPACT Study Steering Committee and Collaborators, Manolis Kogevinas, Kathryn L. Penney, Manuel R. Teixeira, Hermann Brenner, Esther M. John, Radka Kaneva, Christopher J. Logothetis, Susan L. Neuhausen, Azad Razack, Lisa F. Newcomb, Canary PASS Investigators, Marija Gamulin, Nawaid Usmani, Frank Claessens, Manuela Gago-Dominguez, Paul A. Townsend, Monique J. Roobol, View ORCID ProfileWei Zheng, The Profile Study Steering Committee, Ian G. Mills, Ole A. Andreassen, Anders M. Dale, View ORCID ProfileTyler M. Seibert, The PRACTICAL Consortium
doi: https://doi.org/10.1101/2020.09.11.20188383
Roshan A. Karunamuni
1Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA
Minh-Phuong Huynh-Le
2Radiation Oncology, George Washington University, Washington, DC
Chun C. Fan
3Center for Human Development, University of California San Diego, La Jolla, CA, USA
Wesley Thompson
4Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, CA, USA
Rosalind A. Eeles
5The Institute of Cancer Research, London, SM2 5NG, UK
Zsofia Kote-Jarai
5The Institute of Cancer Research, London, SM2 5NG, UK
Kenneth Muir
6Division of Population Health, Health Services Research and Primary Care, University of Manchester, Oxford Road, Manchester, M13 9PL, UK
Artitaya Lophatananon
6Division of Population Health, Health Services Research and Primary Care, University of Manchester, Oxford Road, Manchester, M13 9PL, UK
7
Johanna Schleutker
8Institute of Biomedicine, University of Turku, Finland
Nora Pashayan
9Department of Applied Health Research, University College London, London, WC1E 7HB, UK
Jyotsna Batra
10Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane QLD 4059, Australia
11Australian Prostate Cancer Research Centre-Qld, Queensland University of Technology, Brisbane; Prostate Cancer Research Program, Monash University, Melbourne; Dame Roma Mitchell Cancer Centre, University of Adelaide, Adelaide; Chris O’Brien Lifehouse and
Henrik Grönberg
12Department of Medical Epidemiology and Biostatistics, Karolinska Institute, SE-171 77 Stockholm, Sweden
Eleanor I. Walsh
13Bristol Medical School, Department of Population Health Sciences, University of Bristol, Bristol, United Kingdom
Emma L. Turner
13Bristol Medical School, Department of Population Health Sciences, University of Bristol, Bristol, United Kingdom
Athene Lane
13Bristol Medical School, Department of Population Health Sciences, University of Bristol, Bristol, United Kingdom
14MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom
Richard M. Martin
13Bristol Medical School, Department of Population Health Sciences, University of Bristol, Bristol, United Kingdom
14MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom
15National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and the University of Bristol, Bristol, United Kingdom
David E. Neal
16Nuffield Department of Surgical Sciences, University of Oxford, Room 6603, Level 6, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK
Jenny L. Donovan
17School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
Freddie C. Hamdy
16Nuffield Department of Surgical Sciences, University of Oxford, Room 6603, Level 6, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK
18Faculty of Medical Science, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
Børge G. Nordestgaard
19Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark
Catherine M. Tangen
20SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Robert J. MacInnis
21Cancer Epidemiology Division, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC 3004, Australia
22Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Grattan Street, Parkville, VIC 3010, Australia
Alicja Wolk
23Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden
Demetrius Albanes
24Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, 20892, USA
Christopher A. Haiman
25Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA 90015, USA
Ruth C. Travis
26Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK
Janet L. Stanford
27Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109-1024, USA
Lorelei A. Mucci
28Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA
Catharine M. L. West
29Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Radiotherapy Related Research, The Christie Hospital NHS Foundation Trust, Manchester, M13 9PL UK
Sune F. Nielsen
30Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200 Copenhagen, Denmark
Adam S. Kibel
31Division of Urologic Surgery, Brigham and Womens Hospital, 75 Francis Street, Boston, MA 02115, USA
Fredrik Wiklund
12Department of Medical Epidemiology and Biostatistics, Karolinska Institute, SE-171 77 Stockholm, Sweden
Olivier Cussenot
32Sorbonne Universite, GRC n°5, AP-HP, Tenon Hospital, 4 rue de la Chine, F-75020 Paris, France
Sonja I. Berndt
24Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, 20892, USA
Stella Koutros
24Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, 20892, USA
Karina Dalsgaard Sørensen
33Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensen Boulevard 99, 8200 Aarhus N, Denmark
Cezary Cybulski
34International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 70-115 Szczecin, Poland
Eli Marie Grindedal
35Department of Medical Genetics, Oslo University Hospital, 0424 Oslo, Norway
Jong Y. Park
36Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA
Sue A. Ingles
37Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA 90015, USA
Christiane Maier
38Humangenetik Tuebingen, Paul-Ehrlich-Str 23, D-72076 Tuebingen, Germany
Robert J. Hamilton
39Dept. of Surgical Oncology, Princess Margaret Cancer Centre, Toronto ON M5G 2M9, Canada
Barry S. Rosenstein
40Department of Radiation Oncology and Department of Genetics and Genomic Sciences, Box 1236, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA
Ana Vega
41Fundación Pública Galega Medicina Xenómica, Santiago de Compostela, 15706, Spain
42
Manolis Kogevinas
43ISGlobal, Barcelona, Spain
Kathryn L. Penney
44Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA 02184, USA
Manuel R. Teixeira
45Department of Genetics, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal
Hermann Brenner
46Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany
Esther M. John
47Departments of Epidemiology & Population Health and of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94304 USA
Radka Kaneva
48Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, 2 Zdrave Str., 1431 Sofia, Bulgaria
Christopher J. Logothetis
49The University of Texas M. D. Anderson Cancer Center, Department of Genitourinary Medical Oncology, 1515 Holcombe Blvd., Houston, TX 77030, USA
Susan L. Neuhausen
50Department of Population Sciences, Beckman Research Institute of the City of Hope, 1500 East Duarte Road, Duarte, CA 91010, 626-256-HOPE (4673)
Azad Razack
51Department of Surgery, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
Lisa F. Newcomb
27Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109-1024, USA
Canary PASS Investigators
27Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109-1024, USA
Marija Gamulin
52Division of Medical Oncology, Urogenital Unit, Department of Oncology, University Hospital Centre Zagreb, University of Zagreb, School of Medicine, 10 000 Zagreb, Croatia
Nawaid Usmani
53Department of Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, Alberta, Canada T6G 1Z2
Frank Claessens
54Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, BE-3000, Belgium
Manuela Gago-Dominguez
55Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, 15706, Santiago de Compostela, Spai
Paul A. Townsend
56Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, Univeristy of Manchester, M13 9WL
Monique J. Roobol
57Department of Urology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
Wei Zheng
58Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 800, Nashville, TN 37232 USA
59
Ian G. Mills
60Center for Cancer Research and Cell Biology, Queen’s University of Belfast, Belfast, UK
Ole A. Andreassen
61NORMENT, KG Jebsen Centre, Oslo University Hospital and University of Oslo, Oslo, Norway
Anders M. Dale
62Department of Radiology, University of California San Diego, La Jolla, CA, USA
Tyler M. Seibert
1Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA
62Department of Radiology, University of California San Diego, La Jolla, CA, USA
63Department of Bioengineering, University of California San Diego, La Jolla, CA, USA
64Institute of Cancer Research, Sutton, SW7 3RPm UK
Data Availability
The data used in this work were obtained from the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) consortium. Readers who are interested in accessing the data must first submit a proposal to the Data Access Committee. If the reader is not a member of the consortium, their concept form must be sponsored by a principal investigator (PI) of one of the PRACTICAL consortium member studies. If approved by the Data Access Committee, PIs within the consortium, each of whom retains ownership of their data submitted to the consortium, can then choose to participate in the specific proposal. In addition, portions of the data are available for request from dbGaP (database of Genotypes and Phenotypes) which is maintained by the National Center for Biotechnology Information (NCBI): https://www.ncbi.nlm.nih.gov/gap/?term=Icogs+prostatehttps://www.ncbi.nlm.nih.gov/gap/?term=Icogs+prostate. Anyone can apply to join the consortium. The eligibility requirements are listed here: http://practical.icr.ac.uk/blog/?page_id=9. Joining the consortium would not guarantee access, as a proposal for access would still be submitted to the Data Access Committee, but there would be no need for a separate member sponsor. Readers may find information about application by using the contact information below: Rosalind Eeles Principal Investigator for PRACTICAL Professor of Oncogenetics Institute of Cancer Research (ICR) Sutton, UK Email: PRACTICAL{at}icr.ac.uk URL: http://practical.icr.ac.uk Tel: ++44 (0)20 8722 4094
Posted September 15, 2020.
Additional SNPs improve the performance of a polygenic hazard score for prostate cancer
Roshan A. Karunamuni, Minh-Phuong Huynh-Le, Chun C. Fan, Wesley Thompson, Rosalind A. Eeles, Zsofia Kote-Jarai, Kenneth Muir, Artitaya Lophatananon, UKGPCS collaborators, Johanna Schleutker, Nora Pashayan, Jyotsna Batra, APCB BioResource (Australian Prostate Cancer BioResource), Henrik Grönberg, Eleanor I. Walsh, Emma L. Turner, Athene Lane, Richard M. Martin, David E. Neal, Jenny L. Donovan, Freddie C. Hamdy, Børge G. Nordestgaard, Catherine M. Tangen, Robert J. MacInnis, Alicja Wolk, Demetrius Albanes, Christopher A. Haiman, Ruth C. Travis, Janet L. Stanford, Lorelei A. Mucci, Catharine M. L. West, Sune F. Nielsen, Adam S. Kibel, Fredrik Wiklund, Olivier Cussenot, Sonja I. Berndt, Stella Koutros, Karina Dalsgaard Sørensen, Cezary Cybulski, Eli Marie Grindedal, Jong Y. Park, Sue A. Ingles, Christiane Maier, Robert J. Hamilton, Barry S. Rosenstein, Ana Vega, The IMPACT Study Steering Committee and Collaborators, Manolis Kogevinas, Kathryn L. Penney, Manuel R. Teixeira, Hermann Brenner, Esther M. John, Radka Kaneva, Christopher J. Logothetis, Susan L. Neuhausen, Azad Razack, Lisa F. Newcomb, Canary PASS Investigators, Marija Gamulin, Nawaid Usmani, Frank Claessens, Manuela Gago-Dominguez, Paul A. Townsend, Monique J. Roobol, Wei Zheng, The Profile Study Steering Committee, Ian G. Mills, Ole A. Andreassen, Anders M. Dale, Tyler M. Seibert, The PRACTICAL Consortium
medRxiv 2020.09.11.20188383; doi: https://doi.org/10.1101/2020.09.11.20188383
Additional SNPs improve the performance of a polygenic hazard score for prostate cancer
Roshan A. Karunamuni, Minh-Phuong Huynh-Le, Chun C. Fan, Wesley Thompson, Rosalind A. Eeles, Zsofia Kote-Jarai, Kenneth Muir, Artitaya Lophatananon, UKGPCS collaborators, Johanna Schleutker, Nora Pashayan, Jyotsna Batra, APCB BioResource (Australian Prostate Cancer BioResource), Henrik Grönberg, Eleanor I. Walsh, Emma L. Turner, Athene Lane, Richard M. Martin, David E. Neal, Jenny L. Donovan, Freddie C. Hamdy, Børge G. Nordestgaard, Catherine M. Tangen, Robert J. MacInnis, Alicja Wolk, Demetrius Albanes, Christopher A. Haiman, Ruth C. Travis, Janet L. Stanford, Lorelei A. Mucci, Catharine M. L. West, Sune F. Nielsen, Adam S. Kibel, Fredrik Wiklund, Olivier Cussenot, Sonja I. Berndt, Stella Koutros, Karina Dalsgaard Sørensen, Cezary Cybulski, Eli Marie Grindedal, Jong Y. Park, Sue A. Ingles, Christiane Maier, Robert J. Hamilton, Barry S. Rosenstein, Ana Vega, The IMPACT Study Steering Committee and Collaborators, Manolis Kogevinas, Kathryn L. Penney, Manuel R. Teixeira, Hermann Brenner, Esther M. John, Radka Kaneva, Christopher J. Logothetis, Susan L. Neuhausen, Azad Razack, Lisa F. Newcomb, Canary PASS Investigators, Marija Gamulin, Nawaid Usmani, Frank Claessens, Manuela Gago-Dominguez, Paul A. Townsend, Monique J. Roobol, Wei Zheng, The Profile Study Steering Committee, Ian G. Mills, Ole A. Andreassen, Anders M. Dale, Tyler M. Seibert, The PRACTICAL Consortium
medRxiv 2020.09.11.20188383; doi: https://doi.org/10.1101/2020.09.11.20188383
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)